Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs

Human Pathology

Volumn 38, Issue 1, 2007, Pages 134-139

  Nishimura, Sadako ^a   Tsuda, Hiroshi ^a,e   Ito, Kiyoshi ^b   Jobo, Toshiko ^c   Yaegashi, Nobuo ^b   Inoue, Takeshi ^a   Sudo, Tamotsu ^d   Berkowitz, Ross S ^e   Mok, Samuel C ^e  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ABC transporter; Clear cell adenocarcinoma; Endometrium; Kidney

Indexed keywords

ABCF2 PROTEIN; PROTEIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLEAR CELL CARCINOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MULTIVARIATE ANALYSIS OF COVARIANCE; OVARY ADENOCARCINOMA; OVARY CANCER; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; UTERUS;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; ATP-BINDING CASSETTE TRANSPORTERS; DIAGNOSIS, DIFFERENTIAL; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OVARIAN NEOPLASMS;

EID: 33845303555     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.06.026     Document Type: Article

References (14)

1. Scully R.E., Young R.H., and Clement P.B. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Atlas of Tumor Pathology. 3rd series, Fascicle 23 (1998), Armed Forces Institute of Pathology, Washington (DC)
2. Russel P. Surface epithelial-stroma tumors of the ovary. In: Kurman R.J. (Ed). Blaustein's pathology of the female genital tract. 4th ed (1994), Springer-Verlag, New York 705-782
3. Goff B.A., Sainz de la Cuesta R., Muntz H.G., et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage 3 disease. Gynecol Oncol 60 (1996) 412-417
4. Behbakht K., Randall T.C., Benjamin I., Morgan M.A., King S., and Rubin S.C. Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol 70 (1998) 255-258
5. Tsuda H., Ito Y.M., Ohashi Y., et al. Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses. Clin Cancer Res 11 (2005) 6880-6888
6. Abeler V.M., Kjorstad K.E., and Berie E. Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population. Int J Gynecol Cancer 2 (1992) 9-22
7. Yagoda A. Phase II cytotoxic chemotherapy trials in RCC: 1983-1988. Prog Clin Biol Res 350 (1990) 227-241
8. Bukowski R.M. Natural history and therapy of metastatic renal cell carcinoma. Cancer 80 (1997) 1198-1220
9. Matias-Guiu X., Lerma E., and Part J. Clear cell tumors of the female genital tract. Semin Diagn Pathol 14 (1997) 233
10. Ryan T.A. Significance tests for multiple comparison of proportions, variances, and other statistics. Psychol Bull 57 (1960) 318-328
11. Bast R.C., Feeney M., Lazarus H., Nadler L.M., Colvin R.B., and Knapp R.C. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68 (1981) 1331-1337
12. Bast Jr. R.C., Klug T.L., St John E., et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309 (1983) 883-887
13. Jacobs I., and Bast Jr. R.C. The CA125 tumour-associated antigen: a review of the literature. Hum Reprod 4 (1989) 1-12
14. Vergote I.B., Bormer O.P., and Abeler V.M. Evaluation of serum CA125 levels in the monitoring of ovarian cancer. Am J Obstet Gynecol 157 (1987) 88-92